Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04543227 · ClinicalTrials.gov registry record
Opioid Laws and Pediatric Use
A clinical trial, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- 980
- Enrollment target
NCT04543227: Completed study, sponsored by Nationwide Children's Hospital.
NCT04543227 is a clinical trial that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 980 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04543227 has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- 980 participants
- Enrollment target
Study Summary
The legitimate need for opioid medications for acute pain management in pediatric trauma patients is recognized, however, the high dose and duration of opioid drugs prescribed by medical providers has been associated with an increased risk of opioid abuse and chronic use by patients. The overarching goal of application is to assess opioid use and outcomes of pediatric patients treated for either burn injuries or knee arthroscopy procedures at a large academic pediatric medical center before and after Ohio opioid prescription rules for acute pain were implemented on August 21, 2017. Also, to evaluate patient use of opioids at 90-days post-treatment.
Primary Outcome
Change in opioid medications prescribed pre-law and post-law (reported in morphine equivalent doses)
Interventions
- BEHAVIORAL Opioid Use 90-Days Post Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 980 participants |
| Start Date | 2020-09-10 |
| Est. Completion | 2023-11-16 |
What the finished NCT04543227 record still lists
NCT04543227 is an observational study that tracks outcomes without assigning an intervention. The registered 980 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Opioid Use 90-Days Post Treatment is the first listed.
NCT04543227 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04543227 about?
NCT04543227 is a clinical study titled "Opioid Laws and Pediatric Use". The legitimate need for opioid medications for acute pain management in pediatric trauma patients is recognized, however, the high dose and duration of opioid drugs prescribed by medical providers has been associated with an increased risk of opioid abuse and chronic use by patients. The overarching...
What is the current status of trial NCT04543227?
This trial is currently completed. The enrollment target is 980 participants. The study started on 2020-09-10. Estimated completion is 2023-11-16.
What interventions are being tested in trial NCT04543227?
The interventions under investigation include: Opioid Use 90-Days Post Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04543227?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06337097 · 980 participants · NA
STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy
- NCT07070232 · 980 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- NCT07184931 · 980 participants · Phase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- NCT07184996 · 980 participants · Phase 3
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI